Murali Ramachandran has filed 3 insider transactions across 1 company since November 2024.
Most recent transaction: a grant/award of 152672 shares of Kairos Pharma, LTD. ($KAPA) on October 08, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 8, 2025 | Kairos Pharma, LTD. | $KAPA | Murali Ramachandran | VP of Research and Development | A | COMMON STOCK | 152672 | $0.00 | 299,529.0000 | 20,821,353 | 103.96% | 0.73% |
| Jan. 1, 2025 | Kairos Pharma, LTD. | $KAPA | Murali Ramachandran | VP of Research and Development | A | COMMON STOCK | 14000 | $0.00 | 147,057.0000 | 13,736,597 | 10.52% | 0.10% |
| Nov. 25, 2024 | Kairos Pharma, LTD. | $KAPA | Murali Ramachandran | VP of Research and Development | P | COMMON STOCK | 200 | $1.59 | 133,057.0000 | 10,562,640 | 0.15% | 0.00% |